24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
32.8% |
|
ALZHEIMERS |
24.8% |
|
ENZYME DYNAMICS |
20.8% |
|
ANTIBODY DYNAMICS |
11.2% |
|
ANTIBODY AFFINITY MATURATION |
10.4% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
31.65% |
|
ANTIBODY DYNAMICS SIMULATION |
28.98% |
|
ANTIBODY AFFINITY MATURATION |
13.16% |
|
ENZYME DYNAMICS |
13.05% |
|
ANTIBODY DYNAMICS |
11.92% |
|
STP6 SUGAR TRANSPORT |
.62% |
|
UNSPECIFIED |
.62% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
36.8% |
|
ANTIBODY DYNAMICS SIMULATION |
19.1% |
|
CANCER |
14.04% |
|
ANTIBODY AFFINITY MATURATION |
13.56% |
|
ANTIBODY DYNAMICS |
11.29% |
|
ENZYME DYNAMICS |
2.85% |
|
ANTIBODY MATURATION SIMULATION |
.87% |
|
STP6 SUGAR TRANSPORT |
.76% |
|
PANTOTHENATE KINASE SIMULATION |
.18% |
|
PARKINSONS |
.18% |
|
MEMBRANE TRANSPORT |
.18% |
|
ATSTP10 SUCROSE TRANSPORT |
.11% |
|
UNSPECIFIED |
.05% |
|
FORCE FIELD PROTEIN DYNAMICS |
.02% |